DiagnoCure Inc. announced earnings results for the six months ended April 30, 2014. For the period, the company reported net loss and comprehensive loss for the six months ended April 30, 2014 was CAD 1.07 million, or CAD 0.02 loss per share, compared to a net loss of CAD 1.64 million, or CAD 0.04 loss per share, for the same period ended April 30, 2013. Total revenues for the six months ended April 30, 2014 were CAD 277,462, compared to CAD 332,178 for the same period ended April 30, 2013.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 43 | |
+40.31% | 54.04B | |
+45.49% | 41.96B | |
-1.56% | 41.92B | |
-7.20% | 28.35B | |
+12.25% | 26.35B | |
-22.14% | 19B | |
+7.05% | 13B | |
+28.87% | 12.28B | |
+24.89% | 12.19B |
- Stock Market
- Equities
- DGCRF Stock
- News 9342-8530 Québec Inc.
- DiagnoCure Inc. Announces Earnings Results for the Six Months Ended April 30, 2014